Integer Holdings Co. (NYSE:ITGR – Free Report) – Equities research analysts at Zacks Research boosted their Q1 2026 earnings estimates for shares of Integer in a report issued on Monday, July 22nd. Zacks Research analyst D. Dey now anticipates that the medical equipment provider will earn $1.66 per share for the quarter, up from their previous estimate of $1.65. The consensus estimate for Integer’s current full-year earnings is $5.27 per share.
Integer (NYSE:ITGR – Get Free Report) last released its quarterly earnings data on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, topping analysts’ consensus estimates of $1.12 by $0.02. The firm had revenue of $414.80 million during the quarter, compared to analyst estimates of $412.78 million. Integer had a return on equity of 11.25% and a net margin of 6.01%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.87 earnings per share.
View Our Latest Analysis on Integer
Integer Stock Down 7.1 %
NYSE ITGR opened at $115.68 on Wednesday. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76. Integer has a 12 month low of $69.40 and a 12 month high of $130.15. The stock’s 50 day moving average is $119.11 and its 200 day moving average is $113.04. The stock has a market cap of $3.88 billion, a PE ratio of 40.03, a P/E/G ratio of 1.86 and a beta of 1.11.
Insider Buying and Selling at Integer
In other news, EVP John A. Harris sold 312 shares of Integer stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total value of $35,256.00. Following the completion of the transaction, the executive vice president now owns 1,157 shares in the company, valued at approximately $130,741. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, EVP John A. Harris sold 312 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total value of $35,256.00. Following the completion of the sale, the executive vice president now directly owns 1,157 shares in the company, valued at $130,741. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP John A. Harris sold 1,521 shares of the business’s stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $120.44, for a total transaction of $183,189.24. Following the transaction, the executive vice president now owns 4,922 shares in the company, valued at approximately $592,805.68. The disclosure for this sale can be found here. Insiders have sold a total of 17,936 shares of company stock worth $2,130,937 over the last ninety days. Company insiders own 2.00% of the company’s stock.
Hedge Funds Weigh In On Integer
Several hedge funds have recently bought and sold shares of ITGR. Vanguard Group Inc. boosted its stake in shares of Integer by 0.4% during the third quarter. Vanguard Group Inc. now owns 3,843,992 shares of the medical equipment provider’s stock valued at $301,484,000 after purchasing an additional 15,300 shares during the period. Raymond James & Associates grew its stake in Integer by 20.3% in the 4th quarter. Raymond James & Associates now owns 48,946 shares of the medical equipment provider’s stock worth $4,850,000 after acquiring an additional 8,246 shares in the last quarter. Assenagon Asset Management S.A. bought a new position in Integer in the 4th quarter worth about $1,375,000. Blue Trust Inc. increased its position in shares of Integer by 483.3% during the fourth quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 377 shares during the period. Finally, LVZ Inc. bought a new stake in shares of Integer during the fourth quarter valued at approximately $239,000. Institutional investors own 99.29% of the company’s stock.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Articles
- Five stocks we like better than Integer
- CD Calculator: Certificate of Deposit Calculator
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Profitably Trade Stocks at 52-Week Highs
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- The Significance of Brokerage Rankings in Stock Selection
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.